“PERSONALIZED THERAPY IN CARDIOLOGY: THE ROLE OF PHARMACOGENETICS AND BIOMARKERS IN THE SELECTION OF ANTIHYPERTENSIVE AND ANTIPLATELET AGENTS - POTENTIAL AND LIMITATIONS OF IMPLEMENTATION”. Genetics and Molecular Research (May 6, 2026). Accessed June 9, 2026. https://geneticsmr.com/index.php/gmr/article/view/890.